Current Science and Practice of Surgical and Nonsurgical Opportunities for Ovarian Cancer Prevention

被引:0
作者
MacArthur, Emily [1 ]
Stone, Rebecca [1 ]
机构
[1] Johns Hopkins Univ, Kelly Gynecol Oncol Serv, Baltimore, MD 21218 USA
关键词
ovarian cancer; prevention; germline genetic mutation; salpingectomy; salpingooophorectomy; genetic testing; REDUCING SALPINGO-OOPHORECTOMY; CONTRACEPTIVES COLLABORATIVE REANALYSIS; TUBAL INTRAEPITHELIAL CARCINOMA; BRCA MUTATION CARRIERS; EPITHELIAL OVARIAN; FALLOPIAN-TUBE; SEROUS CARCINOMA; INTRAUTERINE-DEVICE; GERMLINE MUTATIONS; PATHOLOGICAL FINDINGS;
D O I
10.1097/GRF.0000000000000900
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Due to improved understanding of ovarian cancer pathogenesis, we have an unprecedented chance to decrease the burden of disease by maximizing opportunities for prevention. Innovations in surgical options for prevention stem from the discovery that many cases directly or indirectly arise from the fallopian tube. Surgical prevention with salpingectomy alone decreases risk by >= 50%. Effective hormonal and nonhormonal chemopreventive agents are also available. Risk stratification is key to ensuring that options for prevention are appropriately matched to individual risk profile. This evidence-based review provides a critical appraisal of the translational health research endeavors supporting ovarian cancer prevention in clinical practice.
引用
收藏
页码:676 / 686
页数:11
相关论文
共 156 条
  • [61] Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis
    Iodice, S.
    Barile, M.
    Rotmensz, N.
    Feroce, I.
    Bonanni, B.
    Radice, P.
    Bernard, L.
    Maisonneuve, P.
    Gandini, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (12) : 2275 - 2284
  • [62] Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study
    Jareid, Mie
    Thalabard, Jean-Christophe
    Aarflot, Morten
    Bovelstad, Hege M.
    Lund, Eiliv
    Braaten, Tonje
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 (01) : 127 - 132
  • [63] Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy
    Johansen, Nora
    Liavaag, Astrid H.
    Iversen, Ole-Erik
    Dorum, Anne
    Braaten, Tonje
    Michelsen, Trond M.
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2017, 96 (05) : 547 - 555
  • [64] Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review
    Kahn, Ryan M.
    Gordhandas, Sushmita
    Godwin, Kendra
    Stone, Rebecca L.
    Worley, Michael J., Jr.
    Lu, Karen H.
    Roche, Kara C. Long
    [J]. JAMA SURGERY, 2023, 158 (11) : 1204 - 1211
  • [65] Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?
    Kahn, Ryan Matthew
    Ahsan, Muhammad Danyal
    Chapman-Davis, Eloise
    Holcomb, Kevin
    Nitecki, Roni
    Rauh-Hain, Jose Alejandro
    Fowlkes, Rana Khan
    Tubito, Francesca
    Pires, Maira
    Christos, Paul J.
    Tkachuk, Kaitlyn
    Krinsky, Hannah
    Sharaf, Ravi N.
    Offit, Kenneth
    Lipkin, Steven
    Frey, Melissa K.
    [J]. FAMILIAL CANCER, 2023, 22 (02) : 127 - 133
  • [66] The disparate origins of ovarian cancers: pathogenesis and prevention strategies
    Karnezis, Anthony N.
    Cho, Kathleen R.
    Gilks, C. Blake
    Pearce, Celeste Leigh
    Huntsman, David G.
    [J]. NATURE REVIEWS CANCER, 2017, 17 (01) : 65 - 74
  • [67] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff, ND
    Satagopan, JM
    Robson, ME
    Scheuer, L
    Hensley, M
    Hudis, CA
    Ellis, NA
    Boyd, J
    Borgen, PI
    Barakat, RR
    Norton, L
    Offit, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1609 - 1615
  • [68] Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
    Khoja, Lilah
    Weber, Rachel Palmieri
    Webb, Penelope M.
    Jordan, Susan J.
    Muthukumar, Aruna
    Chang-Claude, Jenny
    Fortner, Renee T.
    Jensen, Allan
    Kjaer, Susanne K.
    Risch, Harvey
    Doherty, Jennifer Anne
    Harris, Holly R.
    Goodman, Marc T.
    Modugno, Francesmary
    Moysich, Kirsten
    Berchuck, Andrew
    Schildkraut, Joellen M.
    Cramer, Daniel
    Terry, Kathryn L.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Minh Tung Phung
    Hanley, Gillian E.
    Wu, Anna H.
    Mukherjee, Bhramar
    McLean, Karen
    Cho, Kathleen
    Pike, Malcolm C.
    Pearce, Celeste Leigh
    Lee, Alice W.
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : 195 - 201
  • [69] Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
    Kindelberger, David W.
    Lee, Yonghee
    Miron, Alexander
    Hirsch, Michelle S.
    Feltmate, Colleen
    Medeiros, Fabiola
    Callahan, Michael J.
    Garner, Elizabeth O.
    Gordon, Robert W.
    Birch, Chandler
    Berkowitz, Ross S.
    Muto, Michael G.
    Crum, Christopher P.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (02) : 161 - 169
  • [70] Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017
    King, Lauren A.
    Michels, Kara A.
    Graubard, Barry I.
    Trabert, Britton
    [J]. CANCER CAUSES & CONTROL, 2021, 32 (06) : 587 - 595